Moderna, Inc.

Pharmaceuticals (registry classification)· Cambridge, Massachusetts, USlistedMRNA (Nasdaq)

Public float

$9.9B

Reported public float (US SEC EDGAR) · as of 2025-06-30

FactReported

View source · Reported public float (SEC)

Public float is the market value of shares held by non-affiliates on one date. It is not market capitalisation.

Key facts

Founded: Unknown
Operating status: Unknown
Jurisdiction: US-DE FactReportedUS SEC EDGAR
Headquarters: 325 BINNEY STREET, CAMBRIDGE, Cambridge, Massachusetts, US, 02142
Legal form: Unknown
Registration: 1682852 (US-SEC)
Website: Not available
Shares outstanding: 399,235,889 as of 2026-07-24 FactReportedUS SEC EDGAR

Annual figures as reported in filings. Each value links to the filing it came from.

Fiscal year end	revenue	operating income	net income	total assets
2025-12-31	$1.94B	-$3.07B	-$2.82B	$12.3B
2024-12-31	$3.24B	-$3.94B	-$3.56B	$14.1B
2023-12-31	$6.85B	-$4.24B	-$4.71B	$18.4B
2022-12-31	$19.3B	$9.42B	$8.36B	$25.9B
2021-12-31	$18.5B	$13.3B	$12.2B	$24.7B

Figure	Value	As of	Basis	Source
Public float · FY2025	$9.9B	2025-06-30	FactReported	US SEC EDGAR
Public float · FY2024	$42.1B	2024-06-30	FactReported	US SEC EDGAR
Public float · FY2023	$40.2B	2023-06-30	FactReported	US SEC EDGAR
Public float · FY2022	$48.8B	2022-06-30	FactReported	US SEC EDGAR
Public float · FY2021	$80.8B	2021-06-30	FactReported	US SEC EDGAR
Public float · FY2020	$25.3B	2020-06-30	FactReported	US SEC EDGAR
Public float · FY2019	$3.38B	2019-06-30	FactReported	US SEC EDGAR
Public float · FY2018	$4.3B	2018-12-07	FactReported	US SEC EDGAR